Nuvation Bio Inc.

2.07
0.09 (4.55%)
At close: Apr 22, 2025, 3:59 PM

Nuvation Bio Statistics

Share Statistics

Nuvation Bio has 338.67M shares outstanding. The number of shares has increased by 36.62% in one year.

Shares Outstanding 338.67M
Shares Change (YoY) 36.62%
Shares Change (QoQ) 0.33%
Owned by Institutions (%) 72.27%
Shares Floating 226.88M
Failed to Deliver (FTD) Shares 64.33K
FTD / Avg. Volume 2.3%

Short Selling Information

The latest short interest is 32.1M, so 9.48% of the outstanding shares have been sold short.

Short Interest 32.1M
Short % of Shares Out 9.48%
Short % of Float 13.27%
Short Ratio (days to cover) 14.5

Valuation Ratios

The PE ratio is -1.26 and the forward PE ratio is -3.08. Nuvation Bio's PEG ratio is 0.

PE Ratio -1.26
Forward PE -3.08
PS Ratio 90.81
Forward PS 1.7
PB Ratio 1.54
P/FCF Ratio -5.48
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Nuvation Bio.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.04, with a Debt / Equity ratio of 0.02.

Current Ratio 9.04
Quick Ratio 9.04
Debt / Equity 0.02
Debt / EBITDA -0.02
Debt / FCF -0.07
Interest Coverage -1737.91

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $35.79K
Profits Per Employee $-2.58M
Employee Count 220
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -25.75% in the last 52 weeks. The beta is 1.47, so Nuvation Bio's price volatility has been higher than the market average.

Beta 1.47
52-Week Price Change -25.75%
50-Day Moving Average 2
200-Day Moving Average 2.58
Relative Strength Index (RSI) 53.07
Average Volume (20 Days) 2.79M

Income Statement

In the last 12 months, Nuvation Bio had revenue of 7.87M and earned -567.94M in profits. Earnings per share was -2.11.

Revenue 7.87M
Gross Profit 795K
Operating Income -592.63M
Net Income -567.94M
EBITDA -566.91M
EBIT -567.6M
Earnings Per Share (EPS) -2.11
Full Income Statement

Balance Sheet

The company has 35.72M in cash and 8.91M in debt, giving a net cash position of 26.81M.

Cash & Cash Equivalents 35.72M
Total Debt 8.91M
Net Cash 26.81M
Retained Earnings -910.74M
Total Assets 540.63M
Working Capital 468.01M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -130.41M and capital expenditures -162K, giving a free cash flow of -130.57M.

Operating Cash Flow -130.41M
Capital Expenditures -162K
Free Cash Flow -130.57M
FCF Per Share -0.49
Full Cash Flow Statement

Margins

Gross margin is 10.1%, with operating and profit margins of -7527.33% and -7213.76%.

Gross Margin 10.1%
Operating Margin -7527.33%
Pretax Margin -7213.76%
Profit Margin -7213.76%
EBITDA Margin -7200.75%
EBIT Margin -7527.33%
FCF Margin -1658.52%

Dividends & Yields

NUVB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for NUVB is $10, which is 402.5% higher than the current price. The consensus rating is "Buy".

Price Target $10
Price Target Difference 402.5%
Analyst Consensus Buy
Analyst Count 4
Stock Forecasts

Scores

Altman Z-Score 0.41
Piotroski F-Score 2